Organization
3SBio, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
3SBio, Inc.
... has secured $25 million in Series B funding. The lead investors were 3SBio and Sequoia China. Also, participating in the round were Danhua Capital, Sangel ...
... M.D., as chief scientific officer. The Series B financing was led by 3SBio and Sequoia China, with participation from new investors Danhua Capital (DHVC), Sangel ...
... market: - Amgen - Johnson & Johnson - Roche - Biocon - 3SBio - Pfizer - Kyowa Hakko Kirin Co Ltd - LG Life Sciences ...
... 3SBio Inc. (01530.HK, the "Group"), a leading Chinese biopharmaceutical company, is pleased to ...
... Inc. ("Therapure" or the "Company") today announced that a joint venture between 3SBio Inc. (HKG:1530) ("3SBio"), a leading global biotechnology company, and CPE Funds (investment ...
... molecules, respectively. Companiesdiscussed in this Hypercholesterolemia Pipeline Review H1 2017 report include 3SBio , AFFiRiS AG, Akcea Therapeutics , Alvogen Korea , ARMO Biosciences , ...
... Report Available athttp://www.reportsnreports.com/reports/1001416-head-and-neck-cancer-pipeline-review-h1-2017.html Companies of the Head and Neck Cancer Market are 3SBio Inc, 4SC AG, AB Science SA, AbbVie Inc, Abion Inc, Accelerated Pharma ...
... and diuretics. Key players of Polycystic kidney disease (PKD) market Pipeline are 3SBio Inc, Angion Biomedica Corp, Aptevo Therapeutics Inc, Conatus Pharmaceuticals Inc, DiscoveryBiomed Inc, ...
... Life Sciences Limited - Kyowa Hakko Kirin Co Ltd - Pfizer - 3SBio - Biocon - Roche - Johnson & Johnson - Amgen Visiongain's study ...
Subscribe now for full coverage on 3SBio, Inc.
Start My Free Trial